Edmund Harrigan, MD

As Senior Vice President of Worldwide Safety and Regulatory for Pfizer from 2012 to 2015, he led a 3,500-person team across 80 countries and was responsible for collecting, interpreting, and reporting clinical safety data for more than 600 marketed products, as well as managing regulatory interactions with global health agencies.

Dr. Harrigan’s previous executive leadership roles at Pfizer include serving as Senior Vice President, Head of Worldwide Business Development; Senior Vice President, Head of Worldwide Regulatory Affairs and Quality Assurance; and Vice President, Head of Neuroscience and Ophthalmology. Earlier in his career at Pfizer, Dr. Harrigan served as Vice President of Clinical Development, Therapeutic Area Head, CNS and Pain. Before entering the pharmaceutical industry in 1990, Dr. Harrigan was a practicing neurologist for seven years.

At MMS, Dr. Harrigan supports the MMS teams in a scientific capacity and offers his expertise to colleagues on clinical and regulatory matters, including MMS business-related strategy. Dr. Harrigan earned his M.D. from the University of Massachusetts in Worcester, Mass.